Author:
Leopoulou Marianna,Ann LeQuang Jo,V. Pergolizzi Joseph,Magnusson Peter
Abstract
Dilated cardiomyopathy (DCM) is characterized by the phenotype of a dilated left ventricle with systolic dysfunction. It is classified as hereditary when it is deemed of genetic origin; more than 50 genes are reported to be related to the condition. Symptoms include, among others, dyspnea, fatigue, arrhythmias, and syncope. Unfortunately, sudden cardiac death may be the first manifestation of the disease. Risk stratification regarding sudden death in hereditary DCM as well as preventive management poses a challenge due to the heterogeneity of the disease. The purpose of this chapter is to present the epidemiology, risk stratification, and preventive strategies of sudden cardiac death in hereditary DCM.
Reference45 articles.
1. Park HY. Hereditary dilated cardiomyopathy: Recent advances in genetic diagnostics. Korean Circulation Journal. 2017;47(3):291-298
2. Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation. 2016;134(23):e579-e646
3. Ganesh SK, Arnett DK, Assimes TL, Basson CT, Chakravarti A, Ellinor PT, et al. Genetics and genomics for the prevention and treatment of cardiovascular disease: Update: A scientific statement from the American Heart Association. Circulation. 2013;128(25):2813-2851
4. Morales A, Hershberger RE. Genetic evaluation of dilated cardiomyopathy. Current Cardiology Reports. 2013;15(7):375
5. NIH, US National Library of Medicine. Genetics Home Reference. Familial dilated cardiomyopathy. Available from: https://ghr.nlm.nih.gov/condition/familial-dilated-cardiomyopathy [Accessed: 22 December 2019]